Gros David-Alexandre C 4
4 · Eledon Pharmaceuticals, Inc. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
Gros David-Alexandre C
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-01+108,000→ 108,000 totalExercise: $3.97Exp: 2032-02-01→ Common Stock (108,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase up to 108,000 shares of Common Stock, which option vests with respect to 27,000 shares on February 1, 2023, and then with respect to 6.25% of the underlying shares quarterly over the three-year period ending February 1, 2026.